# FDA removes suicide warning for obesity drug class, approves pill, requests heart safety study.

- slug: fda-removes-suicide-warning-for-obesity-drug-class-approves-pill-requests-heart-safety-study
- date: 2026-04-14
- category: Biotech & Life Sciences

The FDA approved Lillys obesity pill in 50 days, fastest new drug in 24 years, then demanded CV safety trials. Six weeks earlier it cleared the GLP-1 class of suicide risk. Those two calls weeks apart show an agency still figuring out what standard obesity drugs should meet.

---